Melqart Asset Management (UK) Ltd CYTK Holdings History
Melqart Asset Management (UK) Ltd's Cytokinetics Inc Holding Summary
As of 2025-03-31, Melqart Asset Management (UK) Ltd held 999,447.00 shares of Cytokinetics Inc(CYTK), totaling $40.17 Mil. This investment constitutes 5.24% of their stock portfolio, and Melqart Asset Management (UK) Ltd now holds 0.84% of the outstanding Cytokinetics Inc(CYTK) stock.
The initial trade took place in 2024Q1. And since then Melqart Asset Management (UK) Ltd has made 2 purchases of CYTK, at an average price of $70.32, for a total of 1.68 Mil shares. In addition, there have been 3 sales at an average price of $53.33 for 676,338.00 shares. Based on historical transaction data and CYTK's current price of $37.31, Melqart Asset Management (UK) Ltd's estimated gain on his CYTK holdings is $-44.49 Mil, reflecting a -37.75% gain to date.
Melqart Asset Management (UK) Ltd CYTK ($37.31) Holding Chart
Melqart Asset Management (UK) Ltd CYTK ($37.31) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
